Literature DB >> 15699134

Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo.

William L Redmond1, Boris C Marincek, Linda A Sherman.   

Abstract

Activation of naive T cells by quiescent APCs results in tolerance through deletion and anergy. The underlying basis for these distinct fates is unclear. Using clone 4 TCR transgenic animals as a source of naive CD8 T cells, we examined the requirements for peripheral deletion in vivo. Our results demonstrate that independent of the amount of Ag used for stimulation, a single dose was insufficient to achieve complete clonal deletion. Instead, further antigenic exposure was required to completely eliminate all of the activated T cells. Additionally, consecutive stimulations with low doses of Ag were highly effective in promoting deletion. In contrast, although stimulation with high doses of Ag initially led to the apoptosis of many of the activated T cells, it induced hyporesponsiveness in a portion of the responding cells, thereby sparing them from further activation and deletion. These data explain why some conditions promote tolerance through clonal deletion whereas others promote anergy. Furthermore, these data provide a framework to devise protocols for effective deletion of potentially autoreactive T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699134     DOI: 10.4049/jimmunol.174.4.2046

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs.

Authors:  Shannon J Turley; Anne L Fletcher; Kutlu G Elpek
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 3.  Targeting cancer-specific mutations by T cell receptor gene therapy.

Authors:  Thomas Blankenstein; Matthias Leisegang; Wolfgang Uckert; Hans Schreiber
Journal:  Curr Opin Immunol       Date:  2015-02-27       Impact factor: 7.486

4.  Contribution of TCR signaling strength to CD8+ T cell peripheral tolerance mechanisms.

Authors:  Trevor R F Smith; Gregory Verdeil; Kristi Marquardt; Linda A Sherman
Journal:  J Immunol       Date:  2014-08-25       Impact factor: 5.422

5.  Apoptosis-regulated low-avidity cancer-specific CD8(+) T cells can be rescued to eliminate HER2/neu-expressing tumors by costimulatory agonists in tolerized mice.

Authors:  Chelsea M Black; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Cancer Immunol Res       Date:  2014-01-17       Impact factor: 11.151

6.  DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation.

Authors:  Doris Lambracht-Washington; Bao-Xi Qu; Min Fu; Larry D Anderson; Olaf Stüve; Todd N Eagar; Roger N Rosenberg
Journal:  Cell Mol Neurobiol       Date:  2011-04-06       Impact factor: 5.046

7.  Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic Cells.

Authors:  Trevor Smith; Xiaotian Lin; Marielle Mello; Kristi Marquardt; Jocelyn Cheung; Binfeng Lu; Linda A Sherman; Grégory Verdeil
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 8.  Tolerance and exhaustion: defining mechanisms of T cell dysfunction.

Authors:  Andrea Schietinger; Philip D Greenberg
Journal:  Trends Immunol       Date:  2013-11-06       Impact factor: 16.687

9.  CD40 ligation reverses T cell tolerance in acute myeloid leukemia.

Authors:  Long Zhang; Xiufen Chen; Xiao Liu; Douglas E Kline; Ryan M Teague; Thomas F Gajewski; Justin Kline
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

10.  Lymph node-resident lymphatic endothelial cells mediate peripheral tolerance via Aire-independent direct antigen presentation.

Authors:  Jarish N Cohen; Cynthia J Guidi; Eric F Tewalt; Hui Qiao; Sherin J Rouhani; Alanna Ruddell; Andrew G Farr; Kenneth S Tung; Victor H Engelhard
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.